Koyfin Home > Directory > Health Care > Alexion Pharm Inc > Cash from Financing Activities

Alexion Pharm Inc Cash from Financing Activities Chart (ALXN)

Alexion Pharm Inc annual/quarterly Cash from Financing Activities from 2010 to 2020.
  • Alexion Pharm Inc Cash from Financing Activities for the quarter ending September 09, 2020 was $-107m a 44.41% decrease of -48m year over year
  • Alexion Pharm Inc Cash from Financing Activities for the last 12 months ending September 09, 2020 was $-598m a -23.64% increase of 141m year over year
  • Alexion Pharm Inc Annual Cash from Financing Activities for 2019 was $-739m a 86.15% decrease of -637m from 2018
  • Alexion Pharm Inc Annual Cash from Financing Activities for 2018 was $-102m a -482.62% increase of 494m from 2017
  • Alexion Pharm Inc Annual Cash from Financing Activities for 2017 was $-597m a -40.16% increase of 240m from 2016
Other Cash Flow Metrics:
  • Alexion Pharm Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $387m a 33.45% increase of 130m year over year
  • Alexion Pharm Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $227m a 35.57% increase of 81m year over year
  • Alexion Pharm Inc Total Revenue for the quarter ending December 12, 2018 was $1,129m a 17.53% increase of 198m year over year
View Chart On Koyfin

Quarterly ALXN Cash from Financing Activities Data

09/2020$-107m
06/2020$-293m
03/2020$-138m
12/2019$-60m
09/2019$-366m
06/2019$-61m
03/2019$-252m
12/2018$3m
09/2018$11m
06/2018$7m

Annual ALXN Cash from Financing Activities Data

2019$-739m
2018$-102m
2017$-597m
2016$-836m
2015$2,985m
2014$7m
2013$72m
2012$666m
2011$39m
2010$39m